Efficacy and safety of anti-CD19 chimeric antigen receptor-T cells immunotherapy in patients with relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis

Authors :: Zhitao Ying
Yuqin Song
Jun Zhu
Publication Year :: 2021
Publisher :: INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021.

Subjects :: Refractory
business.industry
Meta-analysis
Anti cd19
medicine.medical_treatment
Cancer research
Medicine
In patient
Immunotherapy
business
B-cell lymphoma
medicine.disease
Chimeric antigen receptor

Full Text Access

Tools